Menno W. J. Prins

Menno W. J. Prins

Auto-generated profile, based on publicly available information

Menno W. J. Prins

Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2014 in Lab on a Chip
Verified
Journal Article
Open access
PDF file
ARAlexander van Reenen
Alexander van Reenen
AJArthur M. de Jong
Arthur M. de Jong
Jaap Den ToonderJaap Den Toonder
Jaap Den Toonder
MPMenno W. J. Prins
Menno W. J. Prins
The demand for easy to use and cost effective medical technologies inspires scientists to develop innovative lab-on-chip technologies for point-of-care in vitro diagnostic testing. To fulfill medical needs, the tests should be rapid, sensitive, quantitative, and miniaturizable, and need to integrate all steps from sample-in to result-out. Here, we review the use of magnetic particles actuated by magnetic fields to perform the different process steps that are required for integrated lab-on-chip diagnostic assays. We discuss the use of magnetic particles to mix fluids, to capture specific analytes, to concentrate analytes, to transfer analytes from one solution to another, to label analytes, to perform stringency and washing steps, and to probe biophysical properties of the analytes, distinguishing methodologies with fluid flow and without fluid flow (stationary microfluidics). Our review focuses on efforts to combine and integrate different magnetically actuated assay steps, with the vision that it will become possible in the future to realize integrated lab-on-chip biosensing assays in which all assay process steps are controlled and optimized by magnetic forces.

29 June 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
EVEmiel W. A. Visser
Emiel W. A. Visser
JYJunhong Yan
Junhong Yan
LILeo J. van Ijzendoorn
Leo J. van Ijzendoorn
MPMenno W. J. Prins
Menno W. J. Prins
Healthcare is in demand of technologies for real-time sensing in order to continuously guard the state of patients. Here we present biomarker-monitoring based on the sensing of particle mobility, a concept wherein particles are coupled to a substrate via a flexible molecular tether, with both the particles and substrate provided with affinity molecules for effectuating specific and reversible interactions. Single-molecular binding and unbinding events modulate the Brownian particle motion and the state changes are recorded using optical scattering microscopy. The technology is demonstrated with DNA and protein as model biomarkers, in buffer and in blood plasma, showing sensitivity to picomolar and nanomolar concentrations. The sensing principle is direct and self-contained, without consuming or producing any reactants. With its basis in reversible interactions and single-molecule resolution, we envisage that the presented technology will enable biosensors for continuous biomarker monitoring with high sensitivity, specificity, and accuracy.

17 October 2017 in The Analyst
Verified
Journal Article
Open access
PDF file
BSBedabrata Saha
Bedabrata Saha
PSPål Songe
Pål Songe
TEToon H. Evers
Toon H. Evers
MPMenno W. J. Prins
Menno W. J. Prins
Antibody accessibility on the nanoparticle surface depends on the surface density rather than on the coupling conditions.

20 February 2019 in Lab on a Chip
Verified
Journal Article
Open access
PDF file
CMC. P. Moerland
C. P. Moerland
LIL. J. van Ijzendoorn
L. J. van Ijzendoorn
MPM. W. J. Prins
M. W. J. Prins
Magnetic particles are widely used in lab-on-chip and biosensing applications, because they have a high surface-to-volume ratio, they can be actuated with magnetic fields and many biofunctionalization options are available. This review focuses on the use of rotating magnetic particles for lab-on-chip applications.

28 August 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
MSM. R. W. Scheepers
M. R. W. Scheepers
LIL. J. van Ijzendoorn
L. J. van Ijzendoorn
MPM. W. J. Prins
M. W. J. Prins
Significance: The selectivity of binding of colloidal particles is an important research topic for the field of targeted drug delivery. Extensive theoretical work has shown that high selectivity can be obtained by using multivalent weak interactions. Here we provide comprehensive experimental proof using DNA-coated particles. The ligand–receptor affinity is varied by changing the number of complementary bases, showing that fewer complementary bases yield a higher binding selectivity. The experimental data and corresponding numerical model simulations demonstrate the scaling behavior between molecular density, molecular affinity, and resulting density selectivity of interparticle binding. These results are important for the design of novel systems for targeted nanoparticle drug delivery.

13 October 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
ABAlissa D. Buskermolen
Alissa D. Buskermolen
YLYu-Ting Lin
Yu-Ting Lin
LSLaura and van Smeden
Laura and van Smeden
RHRik B. van Haaften
Rik B. van Haaften
JYJunhong Yan
Junhong Yan
MPMenno W. J. Prins
Menno W. J. Prins
There is a need for sensing technologies that can continuously monitor concentration levels of critical biomolecules in applications such as patient care, fundamental biological research, biotechnology and food industry, as well as the environment. However, it is fundamentally difficult to develop measurement technologies that are not only sensitive and specific, but also allow monitoring over a broad concentration range and over long timespans. Here we describe a continuous biomolecular sensing methodology based on the free diffusion of biofunctionalized particles hovering over a sensor surface. The method records digital events due to single-molecule interactions and enables biomarker monitoring at picomolar to micromolar concentrations without consuming any reagents. We demonstrate the affinity-based sensing methodology for DNA-based sandwich and competition assays, and for an antibody-based cortisol assay. Additionally, the sensor can be dried, facilitating storage over weeks while maintaining its sensitivity. We foresee that this will enable the development of continuous monitoring sensors for applications in fundamental research, for studies on organs on a chip, for the monitoring of patients in critical care, and for the monitoring of industrial processes and bioreactors as well as ecological systems.